Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 10430644
[patent_doc_number] => 20150315656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-05
[patent_title] => 'Methods and Kits for Monitoring Response to Radiation Therapies in Cancer'
[patent_app_type] => utility
[patent_app_number] => 14/649468
[patent_app_country] => US
[patent_app_date] => 2013-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 25154
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14649468
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/649468 | Methods and kits for monitoring response to radiation therapies in cancer | Dec 2, 2013 | Issued |
Array
(
[id] => 9670428
[patent_doc_number] => 20140234291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'GENETIC POLYMORPHISMS ASSOCIATED WITH RHEUMATOID ARTHRITIS, METHODS OF DETECTION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/081397
[patent_app_country] => US
[patent_app_date] => 2013-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 59940
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14081397
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/081397 | GENETIC POLYMORPHISMS ASSOCIATED WITH RHEUMATOID ARTHRITIS, METHODS OF DETECTION AND USES THEREOF | Nov 14, 2013 | Abandoned |
Array
(
[id] => 10399796
[patent_doc_number] => 20150284806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'MATERIALS AND METHODS FOR DETERMINING SUSCEPTIBILITY OR PREDISPOSITION TO CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/646559
[patent_app_country] => US
[patent_app_date] => 2013-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14882
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14646559
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/646559 | MATERIALS AND METHODS FOR DETERMINING SUSCEPTIBILITY OR PREDISPOSITION TO CANCER | Nov 13, 2013 | Abandoned |
Array
(
[id] => 9339551
[patent_doc_number] => 20140066332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'METHODS FOR THE DIAGNOSIS OF FETAL DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/073685
[patent_app_country] => US
[patent_app_date] => 2013-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 28986
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14073685
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/073685 | METHODS FOR THE DIAGNOSIS OF FETAL DISEASE | Nov 5, 2013 | Abandoned |
Array
(
[id] => 9757244
[patent_doc_number] => 20140287940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'METHOD OF DIAGNOSING NEOPLASMS - II'
[patent_app_type] => utility
[patent_app_number] => 14/057812
[patent_app_country] => US
[patent_app_date] => 2013-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 62930
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14057812
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/057812 | METHOD OF DIAGNOSING NEOPLASMS - II | Oct 17, 2013 | Abandoned |
Array
(
[id] => 10367410
[patent_doc_number] => 20150252415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'ARID1B AND NEUROBLASTOMA'
[patent_app_type] => utility
[patent_app_number] => 14/435998
[patent_app_country] => US
[patent_app_date] => 2013-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9352
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435998
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/435998 | ARID1B AND NEUROBLASTOMA | Oct 13, 2013 | Abandoned |
Array
(
[id] => 9643380
[patent_doc_number] => 20140221484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/045416
[patent_app_country] => US
[patent_app_date] => 2013-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 139905
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14045416
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/045416 | GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF | Oct 2, 2013 | Abandoned |
Array
(
[id] => 14058421
[patent_doc_number] => 10233495
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-19
[patent_title] => Methods and compositions for screening and treating developmental disorders
[patent_app_type] => utility
[patent_app_number] => 14/039770
[patent_app_country] => US
[patent_app_date] => 2013-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 6
[patent_no_of_words] => 314615
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14039770
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/039770 | Methods and compositions for screening and treating developmental disorders | Sep 26, 2013 | Issued |
Array
(
[id] => 10594794
[patent_doc_number] => 09315871
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-19
[patent_title] => 'Mutation detection probe, mutation detection method, method of evaluating drug efficacy, and mutation detection kit'
[patent_app_type] => utility
[patent_app_number] => 14/029831
[patent_app_country] => US
[patent_app_date] => 2013-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 23
[patent_no_of_words] => 17928
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14029831
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/029831 | Mutation detection probe, mutation detection method, method of evaluating drug efficacy, and mutation detection kit | Sep 17, 2013 | Issued |
Array
(
[id] => 9223483
[patent_doc_number] => 20140018258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'METHODS FOR GENETIC ANALYSIS'
[patent_app_type] => utility
[patent_app_number] => 14/030091
[patent_app_country] => US
[patent_app_date] => 2013-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 27091
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14030091
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/030091 | METHODS FOR GENETIC ANALYSIS | Sep 17, 2013 | Abandoned |
Array
(
[id] => 9211625
[patent_doc_number] => 20140010802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'SYSTEMS AND METHODS FOR DIAGNOSING A PREDISPOSITION TO DEVELOP CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/969986
[patent_app_country] => US
[patent_app_date] => 2013-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17809
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13969986
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/969986 | SYSTEMS AND METHODS FOR DIAGNOSING A PREDISPOSITION TO DEVELOP CANCER | Aug 18, 2013 | Abandoned |
Array
(
[id] => 10347921
[patent_doc_number] => 20150232927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'EVAULATION OF DUF1220 COPY NUMBER AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/422083
[patent_app_country] => US
[patent_app_date] => 2013-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15219
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422083
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/422083 | EVAULATION OF DUF1220 COPY NUMBER AND METHODS OF USING THE SAME | Aug 14, 2013 | Abandoned |
Array
(
[id] => 9191409
[patent_doc_number] => 20130330724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'RISK ASSESSMENT FOR ADVERSE DRUG REACTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/966996
[patent_app_country] => US
[patent_app_date] => 2013-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10809
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13966996
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/966996 | Risk assessment for adverse drug reactions | Aug 13, 2013 | Issued |
Array
(
[id] => 9491028
[patent_doc_number] => 20140141435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'DIAGNOSIS OF SEPSIS'
[patent_app_type] => utility
[patent_app_number] => 13/965038
[patent_app_country] => US
[patent_app_date] => 2013-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 85
[patent_figures_cnt] => 85
[patent_no_of_words] => 129187
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13965038
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/965038 | DIAGNOSIS OF SEPSIS | Aug 11, 2013 | Abandoned |
13/805544 | OLFACTORY RECEPTOR COPY NUMBER ASSOCIATION WITH AGE AT ONSET OF ALZHEIMER'S DISEASE | Aug 11, 2013 | Abandoned |
Array
(
[id] => 9175140
[patent_doc_number] => 20130317125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'NOVEL SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINATIONS OF NOVEL AND KNOWN POLYMORPHISMS FOR DETERMINING THE ALLELE-SPECIFIC EXPRESSION OF THE IGF2 GENE'
[patent_app_type] => utility
[patent_app_number] => 13/961802
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 21468
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13961802
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/961802 | NOVEL SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINATIONS OF NOVEL AND KNOWN POLYMORPHISMS FOR DETERMINING THE ALLELE-SPECIFIC EXPRESSION OF THE IGF2 GENE | Aug 6, 2013 | Abandoned |
Array
(
[id] => 9175139
[patent_doc_number] => 20130317124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'NOVEL SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINATIONS OF NOVEL AND KNOWN POLYMORPHISMS FOR DETERMINING THE ALLELE-SPECIFIC EXPRESSION OF THE IGF2 GENE'
[patent_app_type] => utility
[patent_app_number] => 13/961788
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 21404
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13961788
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/961788 | NOVEL SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINATIONS OF NOVEL AND KNOWN POLYMORPHISMS FOR DETERMINING THE ALLELE-SPECIFIC EXPRESSION OF THE IGF2 GENE | Aug 6, 2013 | Abandoned |
Array
(
[id] => 9174364
[patent_doc_number] => 20130316349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'N-METHYLPURINE DNA GLYCOSYLASE AND POLYMERASE BETA AS BIOMARKERS FOR ALKYLATOR CHEMOTHERAPY POTENTIATION'
[patent_app_type] => utility
[patent_app_number] => 13/961526
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 22118
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13961526
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/961526 | N-METHYLPURINE DNA GLYCOSYLASE AND POLYMERASE BETA AS BIOMARKERS FOR ALKYLATOR CHEMOTHERAPY POTENTIATION | Aug 6, 2013 | Abandoned |
Array
(
[id] => 9537607
[patent_doc_number] => 20140162255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'NOVEL SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINATIONS OF NOVEL AND KNOWN POLYMORPHISMS FOR DETERMINING THE ALLELE-SPECIFIC EXPRESSION OF THE IGF2 GENE'
[patent_app_type] => utility
[patent_app_number] => 13/961794
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 21468
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13961794
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/961794 | NOVEL SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINATIONS OF NOVEL AND KNOWN POLYMORPHISMS FOR DETERMINING THE ALLELE-SPECIFIC EXPRESSION OF THE IGF2 GENE | Aug 6, 2013 | Abandoned |
Array
(
[id] => 10282101
[patent_doc_number] => 20150167098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'METHODS FOR CHARACTERIZING PATIENTS WITH COLON CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/415557
[patent_app_country] => US
[patent_app_date] => 2013-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 21555
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14415557
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/415557 | METHODS FOR CHARACTERIZING PATIENTS WITH COLON CANCER | Jul 16, 2013 | Abandoned |